Syndecan-1-dependent lacritin-like cell-surface complex (SDC1-LACRT-like complex)

The syndecan-1-dependent lacritin-like cell-surface complex is a specialized receptor assembly found on the surface of pancreatic islet beta-cells. It primarily consists of the heparan sulfate proteoglycan syndecan-1 (SDC1) acting as a co-receptor or scaffold for lacritin or lacritin-like proteins, which are traditionally known for their roles in tear film stability and corneal epithelial health. In the context of the pancreas, this complex plays a critical role in promoting beta-cell survival and protecting against stress-induced apoptosis, which is vital for maintaining insulin production and glucose regulation (Ma et al., 2015, Journal of Biological Chemistry). Research indicates that the activation of this complex by lacritin-like ligands triggers pro-survival signaling pathways, including the activation of protein kinase C alpha (PKCalpha) and the transcription factor NFAT. This signaling axis is particularly relevant in the pathogenesis of diabetes, where beta-cell mass is depleted due to inflammatory or metabolic stress. Therapeutic targeting of this complex using recombinant lacritin or mimetic peptides represents a novel approach to preserving beta-cell function and treating both Type 1 and Type 2 diabetes. However, because syndecan-1 is widely expressed in various epithelial tissues, ensuring the specificity of drugs targeting this complex remains a significant pharmacological challenge.

Other names

Syndecan-1/Lacritin-like protein complexSDC1-dependent lacritin receptor complexLacritin-like signaling complex on beta-cells

The complex acts as a receptor for lacritin or lacritin-like ligands, triggering downstream signaling pathways such as PKCalpha and NFAT to promote beta-cell survival and maintain glucose homeostasis.